Medtronic Loses Another Jury Trial Over Stent Patents

Law360, New York (March 14, 2005, 12:00 AM EST) -- Fresh off its loss against rival Guidant in a patent dispute over drug-coated stents, medical device maker Medtronic said Monday it has lost another dispute against Johnson & Johnson Inc.’s Cordis Corp. in a Delaware jury retrial.

The 1997 lawsuit was retried last week in the U.S. District Court for the District of Delaware after Chief U.S. District Judge Sue L. Robinson overturned a $271 million jury verdict against Medtronic in 2002, and the U.S. Court of Appeals for the Federal Circuit reviewed the case....
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.